20th Biosimilar Medicines Conference insights

🌟 Insights from Day 2 of last week’s Biosimilar Medicines Conference in Amsterdam! Last Friday’s sessions highlighted key updates from global regulators, including the FDA, European Medicines Agency, ANVISA in Brazil and the Medicines and Healthcare products Regulatory Agency. Discussions have shifted away from the need for confirmatory efficacy studies to focus on comprehensive physicochemical […]